MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹2,413 Cr |
Mar2024 | ₹2,152 Cr |
Mar2023 | ₹1,813 Cr |
Mar2022 | ₹920 Cr |
Mar2021 | ₹1,137 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹2,413 Cr | 12.12 | |
Mar2024 | ₹2,152 Cr | 18.70 | |
Mar2023 | ₹1,813 Cr | 97.15 | |
Mar2022 | ₹920 Cr | -19.12 | |
Mar2021 | ₹1,137 Cr | - |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹101,098.8 Cr | -1.3% | -4.3% | -3.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,063.0 Cr | 3% | 3.5% | -15.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,749.0 Cr | 3.1% | -4.8% | 4.9% | Stock Analytics | |
CIPLA | ₹122,429.0 Cr | 1.1% | -4% | -8.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,928.0 Cr | -1.4% | -2.6% | 4.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,168.0 Cr | -0.4% | -1.1% | -7.8% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -1.3% |
-4.3% |
-3.3% |
SENSEX | 0.1% |
1.3% |
-5.1% |
You may also like the below Video Courses